CStone Pharmaceuticals 2616.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 3:42 PM CTT
1.06quote price arrow down-0.03 (-2.75%)
Volume
2,918,500
52 week range
0.80 - 3.33
Loading...
  • Open1.09
  • Day High1.13
  • Day Low1.01
  • Prev Close1.09
  • 52 Week High3.33
  • 52 Week High Date05/02/23
  • 52 Week Low0.80
  • 52 Week Low Date04/05/24

Key Stats

  • Market Cap147.65M
  • Shares Out1,284.19M
  • 10 Day Average Volume2.55M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.3

KEY STATS

  • Open1.09
  • Day High1.13
  • Day Low1.01
  • Prev Close1.09
  • 52 Week High3.33
  • 52 Week High Date05/02/23
  • 52 Week Low0.80
  • 52 Week Low Date04/05/24
  • Market Cap147.65M
  • Shares Out1,284.19M
  • 10 Day Average Volume2.55M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.3

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-3.31
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CStone Pharmaceuticals

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
Wei Li Ph.D.
Non-Executive Chairman of the Board
Jianxin Yang M.D., Ph.D.
Chief Executive Officer, Executive Director
Jun Cheng
Vice President - Finance
Address
1000 Zhangheng Road Bldg 25
Pudong New District
Suzhou, JNG
200072
China